nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00467	0.00521	CcSEcCtD
Flumazenil—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.0046	0.00514	CcSEcCtD
Flumazenil—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00443	0.00495	CcSEcCtD
Flumazenil—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00439	0.0049	CcSEcCtD
Flumazenil—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00434	0.00485	CcSEcCtD
Flumazenil—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00427	0.00476	CcSEcCtD
Flumazenil—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00419	0.00468	CcSEcCtD
Flumazenil—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00418	0.00466	CcSEcCtD
Flumazenil—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00408	0.00456	CcSEcCtD
Flumazenil—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00404	0.00451	CcSEcCtD
Flumazenil—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00404	0.00451	CcSEcCtD
Flumazenil—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00402	0.00449	CcSEcCtD
Flumazenil—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00397	0.00443	CcSEcCtD
Flumazenil—Hiccups—Prednisolone—chronic obstructive pulmonary disease	0.00392	0.00438	CcSEcCtD
Flumazenil—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.0039	0.00435	CcSEcCtD
Flumazenil—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00382	0.00427	CcSEcCtD
Flumazenil—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00382	0.00427	CcSEcCtD
Flumazenil—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00375	0.00419	CcSEcCtD
Flumazenil—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.0037	0.00413	CcSEcCtD
Flumazenil—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00367	0.0041	CcSEcCtD
Flumazenil—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00367	0.00409	CcSEcCtD
Flumazenil—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00365	0.00408	CcSEcCtD
Flumazenil—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00354	0.00396	CcSEcCtD
Flumazenil—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00354	0.00396	CcSEcCtD
Flumazenil—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00353	0.00394	CcSEcCtD
Flumazenil—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.0035	0.00391	CcSEcCtD
Flumazenil—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.0035	0.00391	CcSEcCtD
Flumazenil—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00347	0.00387	CcSEcCtD
Flumazenil—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00342	0.00382	CcSEcCtD
Flumazenil—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00342	0.00381	CcSEcCtD
Flumazenil—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00339	0.00378	CcSEcCtD
Flumazenil—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.00337	0.00376	CcSEcCtD
Flumazenil—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00337	0.00376	CcSEcCtD
Flumazenil—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00334	0.00373	CcSEcCtD
Flumazenil—Delirium—Prednisone—chronic obstructive pulmonary disease	0.00331	0.0037	CcSEcCtD
Flumazenil—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00331	0.0037	CcSEcCtD
Flumazenil—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00329	0.00367	CcSEcCtD
Flumazenil—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00326	0.00365	CcSEcCtD
Flumazenil—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00325	0.00363	CcSEcCtD
Flumazenil—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00325	0.00363	CcSEcCtD
Flumazenil—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00324	0.00361	CcSEcCtD
Flumazenil—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00321	0.00358	CcSEcCtD
Flumazenil—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00321	0.00358	CcSEcCtD
Flumazenil—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.0032	0.00357	CcSEcCtD
Flumazenil—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00319	0.00356	CcSEcCtD
Flumazenil—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00319	0.00356	CcSEcCtD
Flumazenil—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00317	0.00354	CcSEcCtD
Flumazenil—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00312	0.00349	CcSEcCtD
Flumazenil—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00311	0.00347	CcSEcCtD
Flumazenil—Tension—Formoterol—chronic obstructive pulmonary disease	0.00311	0.00347	CcSEcCtD
Flumazenil—GABRA6—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00308	0.0295	CbGpPWpGaD
Flumazenil—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00308	0.00344	CcSEcCtD
Flumazenil—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00307	0.00343	CcSEcCtD
Flumazenil—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00307	0.00343	CcSEcCtD
Flumazenil—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00307	0.00343	CcSEcCtD
Flumazenil—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00307	0.00342	CcSEcCtD
Flumazenil—GABRA4—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00305	0.0292	CbGpPWpGaD
Flumazenil—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00302	0.00338	CcSEcCtD
Flumazenil—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00296	0.00331	CcSEcCtD
Flumazenil—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00296	0.00331	CcSEcCtD
Flumazenil—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00294	0.00328	CcSEcCtD
Flumazenil—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00294	0.00328	CcSEcCtD
Flumazenil—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00293	0.00327	CcSEcCtD
Flumazenil—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00291	0.00325	CcSEcCtD
Flumazenil—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00291	0.00325	CcSEcCtD
Flumazenil—Tremor—Montelukast—chronic obstructive pulmonary disease	0.0029	0.00324	CcSEcCtD
Flumazenil—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.0029	0.00324	CcSEcCtD
Flumazenil—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00289	0.00323	CcSEcCtD
Flumazenil—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00287	0.00321	CcSEcCtD
Flumazenil—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00285	0.00319	CcSEcCtD
Flumazenil—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00285	0.00319	CcSEcCtD
Flumazenil—Hiccups—Prednisone—chronic obstructive pulmonary disease	0.00285	0.00318	CcSEcCtD
Flumazenil—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00285	0.00318	CcSEcCtD
Flumazenil—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.0028	0.00313	CcSEcCtD
Flumazenil—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.0028	0.00313	CcSEcCtD
Flumazenil—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.0028	0.00312	CcSEcCtD
Flumazenil—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.0028	0.00312	CcSEcCtD
Flumazenil—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.0031	CcSEcCtD
Flumazenil—Cough—Formoterol—chronic obstructive pulmonary disease	0.00276	0.00308	CcSEcCtD
Flumazenil—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00276	0.00308	CcSEcCtD
Flumazenil—GABRA6—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00275	0.0263	CbGpPWpGaD
Flumazenil—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00275	0.00307	CcSEcCtD
Flumazenil—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00274	0.00306	CcSEcCtD
Flumazenil—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00273	0.00305	CcSEcCtD
Flumazenil—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00273	0.00305	CcSEcCtD
Flumazenil—GABRA4—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00271	0.026	CbGpPWpGaD
Flumazenil—GABRA5—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00271	0.0259	CbGpPWpGaD
Flumazenil—Cough—Montelukast—chronic obstructive pulmonary disease	0.0027	0.00302	CcSEcCtD
Flumazenil—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.0027	0.00301	CcSEcCtD
Flumazenil—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.0027	0.00301	CcSEcCtD
Flumazenil—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00269	0.00301	CcSEcCtD
Flumazenil—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00269	0.00301	CcSEcCtD
Flumazenil—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00269	0.00301	CcSEcCtD
Flumazenil—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00268	0.003	CcSEcCtD
Flumazenil—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00268	0.003	CcSEcCtD
Flumazenil—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.003	CcSEcCtD
Flumazenil—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00266	0.00297	CcSEcCtD
Flumazenil—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00266	0.00297	CcSEcCtD
Flumazenil—GABRA3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00266	0.0254	CbGpPWpGaD
Flumazenil—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00264	0.00295	CcSEcCtD
Flumazenil—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00263	0.00294	CcSEcCtD
Flumazenil—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00263	0.00294	CcSEcCtD
Flumazenil—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00263	0.00294	CcSEcCtD
Flumazenil—GABRA2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00261	0.025	CbGpPWpGaD
Flumazenil—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00261	0.00291	CcSEcCtD
Flumazenil—GABRB3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00259	0.0248	CbGpPWpGaD
Flumazenil—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00288	CcSEcCtD
Flumazenil—GABRG2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00255	0.0244	CbGpPWpGaD
Flumazenil—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00254	0.00284	CcSEcCtD
Flumazenil—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00254	0.00284	CcSEcCtD
Flumazenil—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00254	0.00283	CcSEcCtD
Flumazenil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00252	0.00281	CcSEcCtD
Flumazenil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00252	0.00281	CcSEcCtD
Flumazenil—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00251	0.00281	CcSEcCtD
Flumazenil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0025	0.00279	CcSEcCtD
Flumazenil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00249	0.00278	CcSEcCtD
Flumazenil—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00245	0.00273	CcSEcCtD
Flumazenil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00241	0.00269	CcSEcCtD
Flumazenil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00241	0.00269	CcSEcCtD
Flumazenil—GABRA5—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00241	0.0231	CbGpPWpGaD
Flumazenil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0024	0.00268	CcSEcCtD
Flumazenil—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.0024	0.00268	CcSEcCtD
Flumazenil—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00239	0.00267	CcSEcCtD
Flumazenil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00238	0.00266	CcSEcCtD
Flumazenil—GABRA3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00237	0.0227	CbGpPWpGaD
Flumazenil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00236	0.00263	CcSEcCtD
Flumazenil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00236	0.00263	CcSEcCtD
Flumazenil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00234	0.00261	CcSEcCtD
Flumazenil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00234	0.00261	CcSEcCtD
Flumazenil—GABRA2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00233	0.0223	CbGpPWpGaD
Flumazenil—GABRB3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00231	0.0221	CbGpPWpGaD
Flumazenil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.00257	CcSEcCtD
Flumazenil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.0023	0.00257	CcSEcCtD
Flumazenil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.0023	0.00256	CcSEcCtD
Flumazenil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.00256	CcSEcCtD
Flumazenil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00229	0.00256	CcSEcCtD
Flumazenil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00228	0.00254	CcSEcCtD
Flumazenil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00227	0.00254	CcSEcCtD
Flumazenil—GABRG2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00227	0.0217	CbGpPWpGaD
Flumazenil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00226	0.00253	CcSEcCtD
Flumazenil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00225	0.00251	CcSEcCtD
Flumazenil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00224	0.00251	CcSEcCtD
Flumazenil—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00223	0.0213	CbGpPWpGaD
Flumazenil—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00223	0.00249	CcSEcCtD
Flumazenil—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00223	0.00249	CcSEcCtD
Flumazenil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00221	0.00247	CcSEcCtD
Flumazenil—Pain—Formoterol—chronic obstructive pulmonary disease	0.00221	0.00247	CcSEcCtD
Flumazenil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00221	0.00246	CcSEcCtD
Flumazenil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00219	0.00245	CcSEcCtD
Flumazenil—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00244	CcSEcCtD
Flumazenil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.00243	CcSEcCtD
Flumazenil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.00242	CcSEcCtD
Flumazenil—Pain—Montelukast—chronic obstructive pulmonary disease	0.00216	0.00242	CcSEcCtD
Flumazenil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00216	0.00241	CcSEcCtD
Flumazenil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00214	0.00239	CcSEcCtD
Flumazenil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00214	0.00239	CcSEcCtD
Flumazenil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00238	CcSEcCtD
Flumazenil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00238	CcSEcCtD
Flumazenil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00213	0.00237	CcSEcCtD
Flumazenil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00212	0.00236	CcSEcCtD
Flumazenil—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.0021	0.00235	CcSEcCtD
Flumazenil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00233	CcSEcCtD
Flumazenil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00229	CcSEcCtD
Flumazenil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00229	CcSEcCtD
Flumazenil—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00204	0.00227	CcSEcCtD
Flumazenil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00203	0.00227	CcSEcCtD
Flumazenil—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.00202	0.00226	CcSEcCtD
Flumazenil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00202	0.00225	CcSEcCtD
Flumazenil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00202	0.00225	CcSEcCtD
Flumazenil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00202	0.00225	CcSEcCtD
Flumazenil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00224	CcSEcCtD
Flumazenil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00224	CcSEcCtD
Flumazenil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.002	0.00224	CcSEcCtD
Flumazenil—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.002	0.00224	CcSEcCtD
Flumazenil—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00198	0.019	CbGpPWpGaD
Flumazenil—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00196	0.00219	CcSEcCtD
Flumazenil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00216	CcSEcCtD
Flumazenil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00212	CcSEcCtD
Flumazenil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00212	CcSEcCtD
Flumazenil—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.0019	0.00212	CcSEcCtD
Flumazenil—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.0019	0.00212	CcSEcCtD
Flumazenil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00208	CcSEcCtD
Flumazenil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.00207	CcSEcCtD
Flumazenil—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00185	0.00207	CcSEcCtD
Flumazenil—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00183	0.00204	CcSEcCtD
Flumazenil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00183	0.00204	CcSEcCtD
Flumazenil—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00182	0.00203	CcSEcCtD
Flumazenil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00201	CcSEcCtD
Flumazenil—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00179	0.002	CcSEcCtD
Flumazenil—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00176	0.00196	CcSEcCtD
Flumazenil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.00195	CcSEcCtD
Flumazenil—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00174	0.00194	CcSEcCtD
Flumazenil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00193	CcSEcCtD
Flumazenil—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00171	0.00191	CcSEcCtD
Flumazenil—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00191	CcSEcCtD
Flumazenil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00191	CcSEcCtD
Flumazenil—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00187	CcSEcCtD
Flumazenil—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00164	0.00183	CcSEcCtD
Flumazenil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.00183	CcSEcCtD
Flumazenil—Rash—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00182	CcSEcCtD
Flumazenil—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00182	CcSEcCtD
Flumazenil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00182	CcSEcCtD
Flumazenil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00182	CcSEcCtD
Flumazenil—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00162	0.00181	CcSEcCtD
Flumazenil—Headache—Formoterol—chronic obstructive pulmonary disease	0.00162	0.00181	CcSEcCtD
Flumazenil—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00162	0.0018	CcSEcCtD
Flumazenil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.0018	CcSEcCtD
Flumazenil—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00161	0.0018	CcSEcCtD
Flumazenil—Rash—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00178	CcSEcCtD
Flumazenil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00159	0.00178	CcSEcCtD
Flumazenil—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00159	0.00178	CcSEcCtD
Flumazenil—Headache—Montelukast—chronic obstructive pulmonary disease	0.00158	0.00177	CcSEcCtD
Flumazenil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00173	CcSEcCtD
Flumazenil—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00155	0.00173	CcSEcCtD
Flumazenil—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00154	0.00172	CcSEcCtD
Flumazenil—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00172	CcSEcCtD
Flumazenil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00172	CcSEcCtD
Flumazenil—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00171	CcSEcCtD
Flumazenil—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00171	CcSEcCtD
Flumazenil—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00171	CcSEcCtD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00151	0.0144	CbGpPWpGaD
Flumazenil—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00168	CcSEcCtD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00149	0.0143	CbGpPWpGaD
Flumazenil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00148	0.00165	CcSEcCtD
Flumazenil—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00163	CcSEcCtD
Flumazenil—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00162	CcSEcCtD
Flumazenil—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00144	0.00161	CcSEcCtD
Flumazenil—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00159	CcSEcCtD
Flumazenil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00137	0.00152	CcSEcCtD
Flumazenil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00135	0.00151	CcSEcCtD
Flumazenil—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00148	CcSEcCtD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00132	0.0127	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.0013	0.0124	CbGpPWpGaD
Flumazenil—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00128	0.00143	CcSEcCtD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00128	0.0122	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00127	0.0121	CbGpPWpGaD
Flumazenil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00141	CcSEcCtD
Flumazenil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.0014	CcSEcCtD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00125	0.0119	CbGpPWpGaD
Flumazenil—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00139	CcSEcCtD
Flumazenil—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00123	0.0118	CbGpPWpGaD
Flumazenil—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00121	0.0116	CbGpPWpGaD
Flumazenil—Pain—Prednisolone—chronic obstructive pulmonary disease	0.0012	0.00134	CcSEcCtD
Flumazenil—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00131	CcSEcCtD
Flumazenil—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00129	CcSEcCtD
Flumazenil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00129	CcSEcCtD
Flumazenil—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00128	CcSEcCtD
Flumazenil—GABRA6—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00113	0.0109	CbGpPWpGaD
Flumazenil—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00125	CcSEcCtD
Flumazenil—GABRA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00112	0.0107	CbGpPWpGaD
Flumazenil—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00112	0.00125	CcSEcCtD
Flumazenil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00124	CcSEcCtD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00109	0.0104	CbGpPWpGaD
Flumazenil—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00108	0.0103	CbGpPWpGaD
Flumazenil—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00108	0.0012	CcSEcCtD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00107	0.0103	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00106	0.0101	CbGpPWpGaD
Flumazenil—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00106	0.0101	CbGpPWpGaD
Flumazenil—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00118	CcSEcCtD
Flumazenil—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00117	CcSEcCtD
Flumazenil—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00104	0.00997	CbGpPWpGaD
Flumazenil—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00103	0.0099	CbGpPWpGaD
Flumazenil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00115	CcSEcCtD
Flumazenil—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00102	0.00973	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000995	0.00953	CbGpPWpGaD
Flumazenil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000992	0.00111	CcSEcCtD
Flumazenil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000983	0.0011	CcSEcCtD
Flumazenil—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000977	0.00935	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00096	0.00919	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000957	0.00916	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000954	0.00913	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000945	0.00904	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000942	0.00902	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000937	0.00897	CbGpPWpGaD
Flumazenil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000925	0.00103	CcSEcCtD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000925	0.00885	CbGpPWpGaD
Flumazenil—GABRA6—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000925	0.00885	CbGpPWpGaD
Flumazenil—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000919	0.00103	CcSEcCtD
Flumazenil—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000913	0.00874	CbGpPWpGaD
Flumazenil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000913	0.00102	CcSEcCtD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000909	0.0087	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000903	0.00864	CbGpPWpGaD
Flumazenil—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000888	0.0085	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000887	0.00849	CbGpPWpGaD
Flumazenil—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000882	0.000985	CcSEcCtD
Flumazenil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000881	0.000984	CcSEcCtD
Flumazenil—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000876	0.000979	CcSEcCtD
Flumazenil—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000876	0.000978	CcSEcCtD
Flumazenil—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000869	0.00832	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000858	0.00821	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00084	0.00804	CbGpPWpGaD
Flumazenil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000838	0.000935	CcSEcCtD
Flumazenil—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000831	0.000928	CcSEcCtD
Flumazenil—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000824	0.00789	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000819	0.00784	CbGpPWpGaD
Flumazenil—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000811	0.00777	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00081	0.00775	CbGpPWpGaD
Flumazenil—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000807	0.000902	CcSEcCtD
Flumazenil—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000805	0.0077	CbGpPWpGaD
Flumazenil—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000797	0.00763	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00079	0.00757	CbGpPWpGaD
Flumazenil—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000783	0.00749	CbGpPWpGaD
Flumazenil—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000778	0.00745	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000775	0.00742	CbGpPWpGaD
Flumazenil—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000764	0.00731	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000763	0.0073	CbGpPWpGaD
Flumazenil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000749	0.000836	CcSEcCtD
Flumazenil—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000749	0.00717	CbGpPWpGaD
Flumazenil—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000736	0.00704	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000731	0.007	CbGpPWpGaD
Flumazenil—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000729	0.000814	CcSEcCtD
Flumazenil—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000719	0.000803	CcSEcCtD
Flumazenil—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000718	0.00687	CbGpPWpGaD
Flumazenil—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000709	0.00678	CbGpPWpGaD
Flumazenil—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.0007	0.0067	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000691	0.00661	CbGpPWpGaD
Flumazenil—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000672	0.000751	CcSEcCtD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000671	0.00642	CbGpPWpGaD
Flumazenil—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000668	0.00639	CbGpPWpGaD
Flumazenil—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000646	0.000722	CcSEcCtD
Flumazenil—Rash—Prednisone—chronic obstructive pulmonary disease	0.000641	0.000716	CcSEcCtD
Flumazenil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00064	0.000715	CcSEcCtD
Flumazenil—Headache—Prednisone—chronic obstructive pulmonary disease	0.000637	0.000711	CcSEcCtD
Flumazenil—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000627	0.00601	CbGpPWpGaD
Flumazenil—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000622	0.00595	CbGpPWpGaD
Flumazenil—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00061	0.00584	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000605	0.00579	CbGpPWpGaD
Flumazenil—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000604	0.000674	CcSEcCtD
Flumazenil—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.0006	0.00574	CbGpPWpGaD
Flumazenil—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000596	0.0057	CbGpPWpGaD
Flumazenil—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000585	0.0056	CbGpPWpGaD
Flumazenil—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000512	0.0049	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00042	0.00402	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000371	0.00355	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000229	0.0022	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.00022	0.00211	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000211	0.00202	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000208	0.00199	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000186	0.00178	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000185	0.00177	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000181	0.00174	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000178	0.00171	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000177	0.0017	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000174	0.00167	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.00016	0.00153	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000152	0.00146	CbGpPWpGaD
Flumazenil—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000129	0.00123	CbGpPWpGaD
Flumazenil—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000126	0.00121	CbGpPWpGaD
Flumazenil—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000125	0.0012	CbGpPWpGaD
Flumazenil—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000111	0.00106	CbGpPWpGaD
Flumazenil—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000109	0.00104	CbGpPWpGaD
Flumazenil—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000107	0.00102	CbGpPWpGaD
Flumazenil—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000106	0.00102	CbGpPWpGaD
Flumazenil—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000104	0.001	CbGpPWpGaD
Flumazenil—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.13e-05	0.000874	CbGpPWpGaD
